Quarterly Result29 May 2026, 07:14 pm
Kabra Drugs FY26: Net Profit After Tax at ₹495.98 Lakhs
AI Summary
Kabra Drugs Ltd. approved the audited financial results for the quarter and financial year ended March 31, 2026. The company's revenue from operations for the year stood at ₹9,274.00 lakhs. Net profit after tax for the year was reported as ₹495.98 lakhs. The Board meeting, which commenced at 05:00 p.m. (IST) and concluded at 06:30 p.m. (IST), also confirmed that Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company.
Key Highlights
- Kabra Drugs' revenue from operations for FY26 reached ₹9,274.00 lakhs.
- The company's net profit after tax for FY26 was ₹495.98 lakhs.
- Basic and diluted EPS for FY26 stood at ₹2.09.
- Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable to the company.
Price Impact
More from KABRADG